After Pfizer, Serum Institute Seeks Emergency Use Nod for Oxford Covid-19 Vaccine Covishield in India - News Femo

Latest news

Monday, December 7, 2020

After Pfizer, Serum Institute Seeks Emergency Use Nod for Oxford Covid-19 Vaccine Covishield in India

A day earlier, the Indian arm of US pharmaceutical giant Pfizer became the first to seek a similar approval from India's drug regulator for its own COVID-19 vaccine in the country, after securing such clearance in the UK and Bahrain. After Pfizer, Serum Institute Seeks Emergency Use Nod for Oxford Covid-19 Vaccine Covishield in India

No comments:

Post a Comment